Business Context and Reporting Period
This Form 6-K filing by GSK plc (the "Company") reports a transaction in its own shares for the month of October 2025. The filing details a share repurchase executed on October 14, 2025, pursuant to a non-discretionary agreement with BNP Paribas SA, announced on September 30, 2025.
Key Financial Metrics and Transaction Details
The filing focuses exclusively on capital structure changes via share buybacks rather than operational financial performance. Key metrics for the October 14, 2025 transaction include:
- Shares Purchased: 270,000 ordinary shares of 31½ pence each.
- Price Range: Lowest price paid was 1,625.50 GBp; highest price paid was 1,649.00 GBp.
- Average Price: Volume-weighted average price paid was 1,641.67 GBp.
- Treasury Holdings: Following this purchase, the Company holds 250,978,844 ordinary shares in treasury.
- Shares in Issue: 4,064,434,985 ordinary shares (excluding Treasury shares).
- Voting Rights: Treasury shares represent 6.17% of total voting rights.
Since the commencement of the current buyback program on September 30, 2025, the Company has purchased an aggregate of 3,514,000 ordinary shares.
Material Changes
The primary material change reported is the reduction of shares in issue and the increase in treasury stock. The filing does not provide comparative financial data (revenue, profit, or cash flow) against prior periods, as it is a transaction-specific report rather than a periodic financial statement.
Guidance, Outlook, and Risks
The filing contains no new operational guidance, outlook, or management commentary regarding business performance. It includes a standard cautionary statement regarding forward-looking statements, noting that actual results may differ materially due to risks described in the Company's Annual Report on Form 20-F for 2024 and Q2 Results for 2025.
Investor Verification Checklist
- Verify the total number of shares held in treasury (250,978,844) against the Company's latest capitalization table.
- Confirm the percentage of voting rights attributable to treasury shares (6.17%) for disclosure threshold calculations under FCA rules.
- Review the non-discretionary agreement terms announced on September 30, 2025, to understand the remaining scope of the buyback program.
- Check the total number of shares in issue (4,064,434,985) for accurate earnings per share (EPS) denominator calculations.